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Abstract 
Background: Type 2 diabetes mellitus is associated with chronic low grade inflammation. One of  the novel inflammatory mark-
ers is hemogram derived neutrophil to lymphocyte ratio (NLR). 
Objective: We aimed to compare NLR levels of  diabetic subjects and healthy controls and to observe possible correlation be-
tween NLR and HbA1c. 
Methods: Medical data of  type 2 diabetic subjects admitted to out-patient clinics of  our institution between April to July in 
2017 were obtained from database and retrospectively analyzed. Control group was chosen from healthy subjects who visited our 
institution for a routine check-up. Anthropometric measures, laboratory data, including, HbA1c, NLR were recorded. 
Results: Median NLR of  the type 2 DM group 2.44  (1.9) was significantly elevated when compared to healthy controls (1.5 
(0.9),  (p<0.001). In addition, a Pearson’s correlation test revealed that NLR was strongly correlated with age (r=0.26, p=0.008), 
fasting plasma glucose (r=0.38, p<0.001), and HbA1c (r=0.49, p<0.001).
Conclusion: Elevated NLR in otherwise healthy subjects may be indicative of  underlying impaired glucose metabolism and 
moreover, NLR should be used as a marker of  diabetic control level in addition to HbA1c in type 2 diabetic subjects.
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Type 2 diabetes mellitus (DM) is one of  the most im-
portant diseases that poses enormous burden to health-
care systems worldwide. Plasma glycated hemoglobin 
(HbA1c) is helpful in establishing the control level of  the 
disease in subjects with DM. Increased levels of  HbA1c 
are associated with worse outcome in the course of  the 
disorder1. Moreover, recent studies suggest that inflam-
matory pathways were activated in type 2 DM2,3. 
Novel inflammatory markers derived from standard 
blood count test are in demand nowadays. One of  these 
derived novel inflammatory markers is neutrophil to lym-
phocyte ratio (NLR), which is got by simply division of  
neutrophil count by lymphocyte count in hemogram. 
It reflects high inflammatory burden of  certain diseas-
es4. Authors found that NLR was significantly elevated 
in subjects with chronic obstructive pulmonary disease 
compared to the healthy population5. Latest studies in lit-
erature have found significant association between NLR 
and many conditions6-10.
The aim of  present study was establishing NLR levels 
of  diabetic subjects and comparing to those in healthy 
controls. We also aimed to find out possible correlation 
between NLR and HbA1c, and microvascular complica-
tions of  type 2 DM.  
Methods
Medical database of  type 2 diabetic subjects who were 
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admitted to out-patient clinics of  our institution between 
April 2017 and July 2017, has been retrospectively ana-
lyzed, after  approval of   institutional board. Control sub-
jects were enrolled from healthy subjects that applied to 
our clinics for a routine check-up. Exclusion criteria were 
as follows: active inflammation, infection, malignancy and 
pregnancy for women patients. Subjects younger than 
18 years of  age were also excluded. Age, gender, height, 
weight, and waist circumference of  the participants were 
obtained from computerized database and recorded. A 
body mass index (BMI) was calculated by dividing of  the 
weight in kilograms to the square of  height in meters. 
Venous blood samples obtained into sterile standard tubes 
containing constant amount of  anticoagulant (K-EDTA). 
Laboratory tests have been held within several minutes 
after blood samples obtained. Serum urea, creatinine, 
fasting plasma glucose, total, HDL and LDL cholester-
ol, triglyceride and albumin were obtained from the same 
database and recorded. Urinary protein excretion, plasma 
HbA1c levels, and data about smoking or drinking habits, 
diabetic nephropathy, retinopathy and neuropathy were 
also obtained and recorded from patient file system. We 
also recorded white blood cell count (WBC), neutrophil 
count (neu), lymphocyte count (lym), hemoglobin (Hb), 
hematocrit (Htc) and platelet count (PLT). A NLR value 
was obtained by division of  neu by lym. 
Data were analyzed by SPSS software. (SPSS 15.0; IBM 
Inc., Chicago, IL, USA). Homogenous variables in study 
groups were expressed as mean ± standard deviation 
and compared by independent samples t test, whereas, 
non-homogenous variables were expressed as   median 
(Interquartile Range) and compared by  Mann-Whitney U 
test. Comparison of  categorical variables in study groups 
was conducted with Chi-square test. Correlation between 
study parameters was done with Pearson’s correlation an-
alyze test. A p value of  <0.05 is considered as statistically 
significant. 
Results
Study population was consisted of  110 subjects; 77 pa-
tients with type 2 DM and 33 healthy controls. Mean age 
of  the patients with type 2 DM (58.6 ± 10.9 years) was 
significantly higher than that of  the control group (39.2 
± 12.4), (p<0.001). 37 of  77 in type 2 DM group and 
22 of  33 in control group were women. Gender was not 
statistically different in study groups (p=0.07). Despite 
height was not statistically different in type 2 DM group 
compared to control group (p=0.11), weight (p<0.001), 
BMI (p<0.001) and waist circumference (p<0.001) were 
significantly elevated in diabetics compared to healthy 
controls.  
Only 3 of  33 subjects were smoking in the control group 
while 22 of  77 in type 2 DM group had smoking as a hab-
it. The difference was reached the statistically significance 
level (p=0.03). None of  the controls and only 3 of  the 
diabetics were drinking alcohol. The difference between 
groups was not significant (p=0.25).
Fasting plasma glucose of  type 2 diabetic patients was 
significantly higher than control subjects (p<0.001). Al-
though Hb (p=0.83), Htc (p=0.39), and PLT (p=0.63) 
were similar in diabetics and controls, NLR of  the type 
2 DM group (2.44 [1.9]) was significantly elevated when 
compared to healthy controls (1.5  [0.9]),  (p<0.001). On 
the other hand, WBC of  diabetic population was signifi-
cantly increased compared to control subjects (p<0.001). 
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Figure 1. Correlation between HbA1c and NLR 
Table 1. General characteristics and laboratory data of the study population 
 
    Type 2 DM group Control Group p 
Gender Men (n) 40 11 0.07   Women (n) 37 22 
    Mean ± SD   
Age (years) 58.6 ±10.9 39.2 ± 12.4 <0.001 
Height (m) 1.63 ± 0.09 1.66 ± 0.08 0.11 
Weight (kg) 82 ± 13 70 ± 9 <0.001 
Waist circumference (cm) 106 ± 12 87 ± 11 <0.001 
BMI (kg/m2) 30.9 ± 5.5 25.4 ± 4.3 <0.001 
Hb (g/dL) 13.6 ± 1.6 13.6 ± 1.8 0.83 
Htc (%) 39.8 ± 4.5 40.7 ± 5.1 0.39 
    Median (IQR)   
Fasting glucose (mg/dL) 160 (69) 93 (10) <0.001 
WBC (k/mm3) 7.5 (2.4) 6.2 (2.2) <0.001 
NLR 2.44 (1.9) 1.5 (0.9) <0.001 
PLT (k/mm3) 230 (86) 234 (57) 0.63 
 
BMI: body mass index, IQR: interquartile range 
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Table 1 shows general characteristics and laboratory data 
of  the study groups. After adjustment of  age difference 
between groups in regression analysis, NLR was still 
significantly different between Type 2 DM and control 
groups (beta:-0.47, p<0.001, 95% CI: -0.73 -0.26).
A Pearson’s correlation test revealed that NLR was 
strongly correlated with age (r=0.25, p=0.008), fasting 
plasma glucose (r=0.35, p<0.001), and HbA1c (r=0.51, 
p<0.001). However, NLR was not correlated with BMI 
or with waist circumference. Figure 1 shows the correla-
tion between HbA1c and NLR.
In sub-group analyze of  diabetic patients, 34 had pro-
teinuria of  various levels and 43 had not. The NLR of  
type 2 diabetics with proteinuria was significantly high-
er than that of  the diabetic patients without proteinuria 
(p=0.008). NLR of  diabetic patients with and without 
retinopathy was not statistically different (p=0.91). Sim-
ilarly, NLR levels of  diabetic subjects with and without 
neuropathy were not significantly different (p=0.17).  
Discussion
Present study showed that NLR levels were increased in 
patients with type 2 DM. This increase probably showed 
the inflammatory burden of  the disease. Moreover, our 
study also showed that NLR further increased as the 
HbA1c level worsened. Therefore, the results of  pres-
ent retrospective study arises the question whether NLR 
could be a novel marker of  diabetic control. 
In 2004, Ohshita et al showed increased WBC count in 
patients with impaired glucose tolerance11. Another study 
from China suggested their results by reporting an as-
sociation between elevated WBC and diabetic complica-
tions12. The increase in WBC mainly reflects the elevated 
neutrophil count in these studies. Similar to the literature, 
we found that WBC was higher in patients with type 2 
DM than control subjects. 
Association between inflammatory conditions and ele-
vated NLR has been well-established13,14. Authors even-
found elevated NLR in another inflammatory condition, 
familial Mediterranean fever15. Increased NLR in type 2 
DM should be explained by the association of  the disease 
to chronic low grade inflammation2,16.  
In a study in 2014, authors compared NLR levels of  pa-
tients with well and poorly controlled diabetes mellitus, 
and found that NLR was higher in poorly controlled di-
abetics compared to well-controlled subjects17. Similar to 
our results in present study, they reported a positive cor-
relation between NLR and HbA1c but not with BMI17. 
The distinction and an addition of  present study is that 
we also figured out increased NLR of  type 2 diabetics 
compared to healthy control subjects. To our knowledge, 
this is the first study reporting such a comparison be-
tween healthy and diabetic populations. 
Underlying mechanisms of  elevated NLR in type 2 DM 
need to be discussed. Neutrophils are the main branch of  
leukocytes in blood stream. Initially, and rapidly they re-
spond to the inflammatory stimuli and neutrophil count 
increases in circulation. On the other hand, interleukin 
levels that increased in inflammatory conditions, cause 
lymphopenia18 and neutrophilia19, together causing ele-
vated NLR. 
Researchers reported that NLR was elevated by aging in 
healthy population20. Diabetic subjects were significantly 
older than controls in present study. However, we did not 
match the age of  study groups for the sake of  avoiding 
selection bias. Other limitations of  our report are ret-
rospective design and relatively small study population. 
They all make our results difficult to interpret. Neverthe-
less, we think that unique findings of  present study are 
quite important to be enlisted in medical literature. 
Conclusion
Elevated NLR in otherwise healthy subjects may be in-
dicative of  underlying impaired glucose metabolism and 
moreover, NLR should be used as a marker of  diabetic 
control level in addition to HbA1c in type 2 diabetic sub-
jects. 
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